Reuters logo
BRIEF-Tonix Pharmaceuticals reports conditional acceptance of Tonmya as proposed brand name for TNX-102 SL
July 6, 2017 / 11:12 AM / in 4 months

BRIEF-Tonix Pharmaceuticals reports conditional acceptance of Tonmya as proposed brand name for TNX-102 SL

July 6 (Reuters) - Tonix Pharmaceuticals Holding Corp :

* Tonix Pharmaceuticals Holding Corp- U.S. FDA conditionally accepted proposed trade name Tonmya for tnx-102 sl for management of ptsd

* Tonix Pharmaceuticals Holding-topline results expected to be reported in 2h of 2018 from phase 3 honor study of tonmya in military-related ptsd

* Tonix Pharmaceuticals Holding Corp- request for proprietary name review for tonmya will be submitted once ptsd new drug application is submitted

* Tonix Pharmaceuticals Holding - request for review of tonmya as proposed name for tnx-102 sl for management of fibromyalgia has been withdrawn at FDA Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below